Last 12 months
Inside the activity.
2 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 23, 2023 Filed Aug 25, 2023 22:08 UTC |
Meurer JanChief Growth Officer
|
GrantRestricted Stock Units · Derivative | 6,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000044 · wk-form4_1693001319.xml · derivative · entry 1 Meurer Jan · CIK 0001967057 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,349 Underlying: Common Stock · 6,349 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:05 UTC |
MERLO LARRY JDirector
|
GrantDeferred Share Units · Derivative | 11,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000042 · wk-form4_1693001137.xml · derivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,854 Underlying: Common Stock · 11,854 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:03 UTC |
Lorenson DonnaChief Corp. Affairs Officer
|
GrantStock Options · Derivative | 37,596 | $0.00 Strike: $20.44 | $0.00 |
DisclosureSEC source: 0001944048-23-000040 · wk-form4_1693000976.xml · derivative · entry 10 Lorenson Donna · CIK 0001967595 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,596 Underlying: Common Stock · 37,596 shares Expires 2030-02-10 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:03 UTC |
Lorenson DonnaChief Corp. Affairs Officer
|
GrantStock Options · Derivative | 27,610 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000040 · wk-form4_1693000976.xml · derivative · entry 9 Lorenson Donna · CIK 0001967595 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,610 Underlying: Common Stock · 27,610 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:03 UTC |
Lorenson DonnaChief Corp. Affairs Officer
|
GrantStock Options · Derivative | 27,795 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000040 · wk-form4_1693000976.xml · derivative · entry 8 Lorenson Donna · CIK 0001967595 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,795 Underlying: Common Stock · 27,795 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:03 UTC |
Lorenson DonnaChief Corp. Affairs Officer
|
GrantStock Options · Derivative | 26,906 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000040 · wk-form4_1693000976.xml · derivative · entry 7 Lorenson Donna · CIK 0001967595 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,906 Underlying: Common Stock · 26,906 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:03 UTC |
Lorenson DonnaChief Corp. Affairs Officer
|
GrantRestricted Stock Units · Derivative | 8,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000040 · wk-form4_1693000976.xml · derivative · entry 6 Lorenson Donna · CIK 0001967595 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,023 Underlying: Common Stock · 8,023 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:03 UTC |
Lorenson DonnaChief Corp. Affairs Officer
|
GrantRestricted Stock Units · Derivative | 7,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000040 · wk-form4_1693000976.xml · derivative · entry 5 Lorenson Donna · CIK 0001967595 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,038 Underlying: Common Stock · 7,038 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:03 UTC |
Lorenson DonnaChief Corp. Affairs Officer
|
GrantRestricted Stock Units · Derivative | 8,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000040 · wk-form4_1693000976.xml · derivative · entry 4 Lorenson Donna · CIK 0001967595 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,371 Underlying: Common Stock · 8,371 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:03 UTC |
Lorenson DonnaChief Corp. Affairs Officer
|
GrantRestricted Stock Units · Derivative | 2,511 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000040 · wk-form4_1693000976.xml · derivative · entry 3 Lorenson Donna · CIK 0001967595 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,511 Underlying: Common Stock · 2,511 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:03 UTC |
Lorenson DonnaChief Corp. Affairs Officer
|
GrantRestricted Stock Units · Derivative | 2,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000040 · wk-form4_1693000976.xml · derivative · entry 2 Lorenson Donna · CIK 0001967595 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,815 Underlying: Common Stock · 2,815 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:03 UTC |
Lorenson DonnaChief Corp. Affairs Officer
|
GrantRestricted Stock Units · Derivative | 3,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000040 · wk-form4_1693000976.xml · derivative · entry 1 Lorenson Donna · CIK 0001967595 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,252 Underlying: Common Stock · 3,252 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:59 UTC |
Lawson CarltonGroup President EMEA
|
GrantStock Options · Derivative | 112,197 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000038 · wk-form4_1693000783.xml · derivative · entry 11 Lawson Carlton · CIK 0001967003 · Group President EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,197 Underlying: Common Stock · 112,197 shares Expires 2033-02-13 F8 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:59 UTC |
Lawson CarltonGroup President EMEA
|
GrantStock Options · Derivative | 117,012 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000038 · wk-form4_1693000783.xml · derivative · entry 10 Lawson Carlton · CIK 0001967003 · Group President EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,012 Underlying: Common Stock · 117,012 shares Expires 2032-02-14 F8 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:59 UTC |
Lawson CarltonGroup President EMEA
|
GrantStock Options · Derivative | 34,225 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000038 · wk-form4_1693000783.xml · derivative · entry 9 Lawson Carlton · CIK 0001967003 · Group President EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,225 Underlying: Common Stock · 34,225 shares Expires 2031-02-08 F8 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F5 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:59 UTC |
Lawson CarltonGroup President EMEA
|
GrantStock Options · Derivative | 31,173 | $0.00 Strike: $20.44 | $0.00 |
DisclosureSEC source: 0001944048-23-000038 · wk-form4_1693000783.xml · derivative · entry 8 Lawson Carlton · CIK 0001967003 · Group President EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,173 Underlying: Common Stock · 31,173 shares Expires 2030-02-10 F8 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F9 · derivative.exercise_date: This award is fully vested Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:59 UTC |
Lawson CarltonGroup President EMEA
|
GrantRestricted Stock Units · Derivative | 9,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000038 · wk-form4_1693000783.xml · derivative · entry 7 Lawson Carlton · CIK 0001967003 · Group President EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,949 Underlying: Common Stock · 9,949 shares Expires not disclosed F6 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F5 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:59 UTC |
Lawson CarltonGroup President EMEA
|
GrantRestricted Stock Units · Derivative | 29,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000038 · wk-form4_1693000783.xml · derivative · entry 6 Lawson Carlton · CIK 0001967003 · Group President EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,618 Underlying: Common Stock · 29,618 shares Expires not disclosed F6 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:59 UTC |
Lawson CarltonGroup President EMEA
|
GrantRestricted Stock Units · Derivative | 34,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000038 · wk-form4_1693000783.xml · derivative · entry 5 Lawson Carlton · CIK 0001967003 · Group President EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,907 Underlying: Common Stock · 34,907 shares Expires not disclosed F6 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F7 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F7 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:59 UTC |
Lawson CarltonGroup President EMEA
|
GrantRestricted Stock Units · Derivative | 3,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000038 · wk-form4_1693000783.xml · derivative · entry 4 Lawson Carlton · CIK 0001967003 · Group President EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,119 Underlying: Common Stock · 3,119 shares Expires not disclosed F2 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F5 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F5 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:59 UTC |
Lawson CarltonGroup President EMEA
|
GrantRestricted Stock Units · Derivative | 11,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000038 · wk-form4_1693000783.xml · derivative · entry 3 Lawson Carlton · CIK 0001967003 · Group President EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,846 Underlying: Common Stock · 11,846 shares Expires not disclosed F2 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:59 UTC |
Lawson CarltonGroup President EMEA
|
GrantRestricted Stock Units · Derivative | 13,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000038 · wk-form4_1693000783.xml · derivative · entry 2 Lawson Carlton · CIK 0001967003 · Group President EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,557 Underlying: Common Stock · 13,557 shares Expires not disclosed F2 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:59 UTC |
Lawson CarltonGroup President EMEA
|
OtherCommon Stock | 1,670 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000038 · wk-form4_1693000783.xml · nonDerivative · entry 1 Lawson Carlton · CIK 0001967003 · Group President EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670 F1 · price: On July 24, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. ("Kenvue") common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:56 UTC |
Howlett HeatherVP & Chief Accounting Officer
|
GrantStock Options · Derivative | 38,626 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000036 · wk-form4_1693000577.xml · derivative · entry 4 Howlett Heather · CIK 0001805274 · VP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,626 Underlying: Common Stock · 38,626 shares Expires 2033-02-13 F6 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:56 UTC |
Howlett HeatherVP & Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 12,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000036 · wk-form4_1693000577.xml · derivative · entry 3 Howlett Heather · CIK 0001805274 · VP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,016 Underlying: Common Stock · 12,016 shares Expires not disclosed F4 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F5 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:56 UTC |
Howlett HeatherVP & Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 27,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000036 · wk-form4_1693000577.xml · derivative · entry 2 Howlett Heather · CIK 0001805274 · VP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,181 Underlying: Common Stock · 27,181 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 10/03/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 10/03/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:56 UTC |
Howlett HeatherVP & Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 4,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000036 · wk-form4_1693000577.xml · derivative · entry 1 Howlett Heather · CIK 0001805274 · VP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,667 Underlying: Common Stock · 4,667 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:48 UTC |
Godbole SeemantiniDirector
|
GrantDeferred Share Units · Derivative | 7,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000030 · wk-form4_1693000078.xml · derivative · entry 1 Godbole Seemantini · CIK 0001759418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,620 Underlying: Common Stock · 7,620 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:51 UTC |
Healey MelanieDirector
|
GrantDeferred Share Units · Derivative | 7,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000032 · wk-form4_1693000278.xml · derivative · entry 2 Healey Melanie · CIK 0001536208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,620 Underlying: Common Stock · 7,620 shares Expires not disclosed F2 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:51 UTC |
Healey MelanieDirector
|
OtherCommon Stock | 151 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001944048-23-000032 · wk-form4_1693000278.xml · nonDerivative · entry 1 Healey Melanie · CIK 0001536208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151 F1 · price: On July 24, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. ("Kenvue") common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:46 UTC |
Franklin TamaraDirector
|
GrantDeferred Share Units · Derivative | 7,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000028 · wk-form4_1692999948.xml · derivative · entry 1 Franklin Tamara · CIK 0001855053 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,620 Underlying: Common Stock · 7,620 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:42 UTC |
Fasolo PeterDirector
|
GrantDeferred Share Units · Derivative | 7,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000026 · wk-form4_1692999726.xml · derivative · entry 2 Fasolo Peter · CIK 0001509999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,620 Underlying: Common Stock · 7,620 shares Expires not disclosed F2 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:42 UTC |
Fasolo PeterDirector
|
OtherCommon Stock | 1,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001944048-23-000026 · wk-form4_1692999726.xml · nonDerivative · entry 1 Fasolo Peter · CIK 0001509999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,863 F1 · price: On July 24, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. ("Kenvue") common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:35 UTC |
ALLISON RICHARD E JRDirector
|
GrantDeferred Share Units · Derivative | 7,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000022 · wk-form4_1692999297.xml · derivative · entry 2 ALLISON RICHARD E JR · CIK 0001622500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,620 Underlying: Common Stock · 7,620 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantStock Options · Derivative | 85,534 | $0.00 Strike: $13.76 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 14 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,534 Underlying: Common Stock · 85,534 shares Expires 2026-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantStock Options · Derivative | 60,650 | $0.00 Strike: $15.62 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 13 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,650 Underlying: Common Stock · 60,650 shares Expires 2027-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantStock Options · Derivative | 48,523 | $0.00 Strike: $17.49 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 12 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,523 Underlying: Common Stock · 48,523 shares Expires 2028-02-11 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantStock Options · Derivative | 48,056 | $0.00 Strike: $17.82 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 11 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,056 Underlying: Common Stock · 48,056 shares Expires 2029-02-11 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantStock Options · Derivative | 89,372 | $0.00 Strike: $20.44 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 10 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,372 Underlying: Common Stock · 89,372 shares Expires 2030-02-10 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantStock Options · Derivative | 52,627 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 9 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,627 Underlying: Common Stock · 52,627 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantStock Options · Derivative | 48,005 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 8 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,005 Underlying: Common Stock · 48,005 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantStock Options · Derivative | 45,375 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 7 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,375 Underlying: Common Stock · 45,375 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantRestricted Stock Units · Derivative | 15,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 6 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,298 Underlying: Common Stock · 15,298 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantRestricted Stock Units · Derivative | 12,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 5 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,149 Underlying: Common Stock · 12,149 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantRestricted Stock Units · Derivative | 14,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 4 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,120 Underlying: Common Stock · 14,120 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantRestricted Stock Units · Derivative | 4,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 3 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,793 Underlying: Common Stock · 4,793 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 ("the Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 ("the Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantRestricted Stock Units · Derivative | 4,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 2 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,860 Underlying: Common Stock · 4,860 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 ("the Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 ("the Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC |
Alvarado LuaniChief People Officer
|
GrantRestricted Stock Units · Derivative | 5,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000024 · wk-form4_1692999605.xml · derivative · entry 1 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,482 Underlying: Common Stock · 5,482 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 ("the Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 ("the Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:53 UTC |
JOHNSON & JOHNSON10% owner
|
OtherCommon Stock | 1,533,830,450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-030660 · wk-form4_1692996787.xml · nonDerivative · entry 1 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,329,550 F1 · kind: Johnson & Johnson disposed of 1,533,830,450 shares of Issuer common stock in exchange for 190,955,436 shares of Johnson & Johnson common stock pursuant to a registered exchange offer to holders of shares of Johnson & Johnson common stock. The final exchange ratio was 8.0324 shares of Issuer common stock per share of Johnson & Johnson common stock accepted in the exchange offer. F1 · price: Johnson & Johnson disposed of 1,533,830,450 shares of Issuer common stock in exchange for 190,955,436 shares of Johnson & Johnson common stock pursuant to a registered exchange offer to holders of shares of Johnson & Johnson common stock. The final exchange ratio was 8.0324 shares of Issuer common stock per share of Johnson & Johnson common stock accepted in the exchange offer. Read SEC document |
| May 11, 2023 Filed May 12, 2023 20:14 UTC |
ALLISON RICHARD E JRDirector
|
PurchaseCommon Stock | 20,000 | $26.26 | $525,232.00 |
DisclosureSEC source: 0001944048-23-000008 · wk-form4_1683922472.xml · nonDerivative · entry 1 ALLISON RICHARD E JR · CIK 0001622500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.215 to $26.29, inclusive. The reporting person undertakes to provide to Kenvue Inc., any security holder of Kenvue Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.